EUROFINS VIRALLIANCE INC has a total of 13 patent applications. Its first patent ever was published in 2001. It filed its patents most often in EPO (European Patent Office), Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology are ORITEST SRO, DNA POLYMERASE TECHNOLOGY INC and ROSETTA GENOMICS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | Australia | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Brazil | 1 | |
#5 | China | 1 | |
#6 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Lebel-Binay Sophie | 9 |
#2 | Dam Elisabeth | 5 |
#3 | Barraud Luc | 5 |
#4 | Zoulim Fabien | 5 |
#5 | Durantel Sandra | 5 |
#6 | Durantel David | 5 |
#7 | Trepo Christian | 4 |
#8 | Race Esther | 3 |
#9 | Clavel Francois | 3 |
#10 | Mammano Fabrizio | 3 |
Publication | Filing date | Title |
---|---|---|
AU2007249129A1 | Novel method for analysing phenotypic characteristics of human immunodeficiency virus (HIV) | |
WO2008047227A2 | Method of assaying hiv-1 tropism for ccr5 and/or cxcr4 co-receptor and/or susceptibility to entry inhibitors | |
EP1914309A1 | Method of assaying HIV-1 tropism for CCR5 and/or CXCR4 co-receptor and/or susceptibility to entry inhibitors | |
EP1696040A1 | Method of genotyping and phenotyping hepatitis B viruses resistant to antiviral molecules | |
AU2002223052B2 | Novel method for analysing phenotypic characteristics of human immunodeficiency virus (HIV) |